Dermata Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Dermata Therapeutics has a total shareholder equity of $3.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.2M and $1.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.95m |
| Equity | US$3.32m |
| Total liabilities | US$1.92m |
| Total assets | US$5.24m |
Financial Position Analysis
Short Term Liabilities: DRMA's short term assets ($5.2M) exceed its short term liabilities ($1.9M).
Long Term Liabilities: DRMA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DRMA is debt free.
Reducing Debt: DRMA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DRMA has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: DRMA is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.